ИностранцамНовостиКонтакты
БОЛЬНИЦЫ УНИВЕРСИТЕТАХАДЖЕТТЕПЕ
  1. Home
  2. Врачи
  3. Доц. д-р Neşe Ünver
Доц. д-р Neşe Ünver

Доц. д-р

Neşe Ünver

Basic Oncology · Онкологическая больница

This page is not yet available in Русский. The Turkish version is shown below.

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (29) ↗

Articles 21

  1. Characterization of Carcinogenesis Resistance in Anatolian Blind Mole-rat Mesenchymal Stem Cells and Assessment of Transcriptomic Signatures.Unver N., Tavukcuoglu E., Budak B., Sezginer O., Ozturk S. C., Ozturk S. E., et al.Stem cells (Dayton, Ohio), 2026 (SCI-Expanded, Scopus)
  2. The impact of aspirin on PD-L1 expression and alteration of M2 polarization in non-small cell lung cancerUnver N., Uluturk S., Tavukcuoglu E., Duymaz Yilmaz E., Kaymaz Y., Esendagli G.Inflammation Research, cilt.74, sa.1, 2025 (SCI-Expanded, Scopus)
  3. Aspirin's effect on macrophages beyond its chemopreventive role in inflammation and cancer.Unver N.Inflammopharmacology, cilt.33, ss.5735-5743, 2025 (SCI-Expanded, Scopus)
  4. Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization.Sezginer O., Unver N.Inflammation research : official journal of the European Histamine Research Society ... [et al.], cilt.73, ss.1411-1423, 2024 (SCI-Expanded, Scopus)
  5. Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approachesUnver N.Clinical and Experimental Medicine, cilt.23, sa.7, ss.3171-3177, 2023 (SCI-Expanded, Scopus)
  6. Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppressionUnver N., Tavukcuoglu E., Esendagli G.Life Sciences, cilt.311, 2022 (SCI-Expanded, Scopus)
  7. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.Tanaka I., Dayde D., Tai M. C., Mori H., Solis L. M., Tripathi S. C., et al.Journal of the National Cancer Institute, cilt.114, ss.290-301, 2022 (SCI-Expanded, Scopus)
  8. In-Silico Analysis of The Correlation Between PD-L1 and Pro-Inflammatory Type Interleukins and The Distribution of Their Potential Primary Sources in KRAS-Mutated Non-Small Cell Lung CarcinomaÜnver N.Acta Medica, cilt.52, sa.3, ss.189-196, 2021 (TRDizin)
  9. Revisiting CCL-type chemokines in breast cancer and its milieu: Prominent targetable chemokines, CCL8 and CCL21.Unver N.Bioscience reports, cilt.41, 2021 (SCI-Expanded, Scopus)
  10. Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.Unver N.Medical oncology (Northwood, London, England), cilt.38, ss.68, 2021 (SCI-Expanded, Scopus)
  11. Cancer stemness as a target for immunotherapy is shaped by pro-inflammatory stress.Unver N.Current stem cell research & therapy, cilt.16, ss.792-800, 2021 (SCI-Expanded, Scopus)
  12. Transcriptional splice variants of CD40 and its prognostic value in breast cancer.Ünver N., Yöyen E., Weber B., Esendağli G.Turkish journal of biology = Turk biyoloji dergisi, cilt.44, ss.73-81, 2020 (SCI-Expanded, Scopus, TRDizin)
  13. Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target.Unver N.Cytokine & growth factor reviews, 2019 (SCI-Expanded, Scopus)
  14. IL22 Promotes <i>Kras</i>-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties.KHOSRAVI N., CAETANO M., CUMPIAN A., Unver N., DE L. G. R. C., NOBLE O., et al.Cancer immunology research, cilt.6, ss.788-797, 2018 (SCI-Expanded, Scopus)
  15. IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.Unver N., MCALLISTER F.Cytokine & growth factor reviews, cilt.41, ss.10-17, 2018 (SCI-Expanded, Scopus)
  16. Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.Unver N., Delgado O., Zeleke K., Cumpian A., Tang X., Caetano M., et al.International journal of cancer, cilt.142, ss.1405-1417, 2018 (SCI-Expanded, Scopus)
  17. Akciğer Tümörigenezinde ve Kanserle İlişkili İnflamasyonda Chemerin'in Düzenleyici Rolü.Ünver N., Esendağlı G., Canpınar H., Güç D., Esendağlı G.Acta Medica, cilt.49, sa.1, ss.16-25, 2018 (TRDizin)
  18. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.HALACLI B., Unver N., HALACLI S., CANPINAR H., ERSOY E., OCAL S., et al.Journal of critical care, cilt.35, ss.185-90, 2016 (SCI-Expanded, Scopus)
  19. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.CAETANO M., ZHANG H., CUMPIAN A., GONG L., Unver N., OSTRIN E., et al.Cancer research, cilt.76, ss.3189-99, 2016 (SCI-Expanded, Scopus)
  20. CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.Unver N., ESENDAGLI G., YILMAZ G., GUC D.Cytokine, cilt.75, ss.330-7, 2015 (SCI-Expanded, Scopus)
  21. Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 geneEMRE S., Unver N., EVANS S., YÜZBAŞIOĞLU A., GÜRAKAN F., GÜMRÜK F., et al.EUROPEAN JOURNAL OF MEDICAL GENETICS, cilt.53, sa.3, ss.141-144, 2010 (SCI-Expanded, Scopus)

Conference papers 6

Kitaplar 2

Контакты

Phone
0312 305 44 08
Department
Basic Oncology, Онкологическая больница

Последнее обновление: